Mar 29, 2017 11:01 am UTC| Business
SUNNYVALE, Calif., March 29, 2017 -- Liquid Robotics® is honored to announce Admiral (ret.) Sir George Zambellas, the former First Sea Lord of the British Royal Navy, will join Liquid Robotics’ global Strategic Advisory...
3D Signatures Completes Assay Validation for Hodgkin’s Lymphoma Test
Mar 29, 2017 11:01 am UTC| Business
WINNIPEG, Manitoba, March 29, 2017 -- 3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), is pleased to announce that it has successfully completed internal analytical assay validation for...
Mitek’s Identity Solutions Selected by Artilium, EU Mobile Virtual Network Provider
Mar 29, 2017 11:01 am UTC| Business
SAN DIEGO and LONDON, March 29, 2017 -- Mitek (NASDAQ:MITK) (www.miteksystems.com), a global leader in mobile capture and identity verification software solutions and Artilium, a leading MVNO/MVNE solution provider in...
Mar 29, 2017 11:01 am UTC| Business
NEW YORK, March 29, 2017 -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), a company that is developing innovative pharmaceutical products to address public health challenges, announced today that it will...
Calithera Biosciences to Present at the 16th Annual Needham Health Care Conference
Mar 29, 2017 11:01 am UTC| Business
SOUTH SAN FRANCISCO, Calif., March 29, 2017 -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor...
Edge Therapeutics to Present at Needham & Company’s 16th Annual Healthcare Conference
Mar 29, 2017 11:01 am UTC| Business
BERKELEY HEIGHTS, N.J., March 29, 2017 -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies in the management of acute, life-threatening conditions,...
Edge Therapeutics to Present at Needham & Company’s 16th Annual Healthcare Conference
Mar 29, 2017 11:01 am UTC| Business
BERKELEY HEIGHTS, N.J., March 29, 2017 -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies in the management of acute, life-threatening conditions,...